Cargando…
A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer
SIMPLE SUMMARY: Cannabinoids have been widely used for pain, nausea, and appetite stimulation, and have also shown anti-tumor activity in preclinical studies of prostate cancer. Epidiolex is an oral cannabidiol solution that is FDA approved for the treatment of certain types of seizures in patients...
Autores principales: | Myint, Zin W., St. Clair, William H., Strup, Stephen E., Yan, Donglin, Li, Ning, Allison, Derek B., McLouth, Laurie E., Ellis, Carleton S., Wang, Peng, James, Andrew C., Hensley, Patrick J., Otto, Danielle E., Arnold, Susanne M., DiPaola, Robert S., Kolesar, Jill M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177512/ https://www.ncbi.nlm.nih.gov/pubmed/37173971 http://dx.doi.org/10.3390/cancers15092505 |
Ejemplares similares
-
Correlation Between Trough Level of Abiraterone and Prostate-Specific Antigen (PSA) Response in Metastatic Hormone-Sensitive Prostate Cancer
por: Myint, Zin W., et al.
Publicado: (2022) -
Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic Parameters
por: Myint, Zin W., et al.
Publicado: (2021) -
Evaluation of Fall and Fracture Risk Among Men With Prostate Cancer Treated With Androgen Receptor Inhibitors: A Systematic Review and Meta-analysis
por: Myint, Zin W., et al.
Publicado: (2020) -
Epidiolex as adjunct therapy for treatment of refractory epilepsy: a comprehensive review with a focus on adverse effects
por: Sekar, Krithiga, et al.
Publicado: (2019) -
Pharmacokinetics of escalating single‐dose administration of cannabidiol to cats
por: Rozental, Aaron J., et al.
Publicado: (2022)